Table 1.

EAE scores of mice treated with control or anti-RGMa antibodies

Treatment group	Mean relapse days	Mean disease score between 20 and 49 days	Mean disease score after 50 days	Score above 3.0 at 70 days
Palivizumab	41.1 ± 3.0	1.15 ± 0.23	3.57 ± 0.35	14/17 (82.3%)
Anti-RGMa (100 μg)	35.2 ± 2.8	0.94 ± 0.19	2.69 ± 0.42	4/9 (44.4%)
Anti-RGMa (200 μg)	44.8 ± 2.8	0.79 ± 0.19	2.32 ± 0.41	5/14 (35.7%)

Mean ± SEM